XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 27, 2023
USD ($)
Dec. 03, 2020
plaintiff
Dec. 31, 2023
claim
Sep. 30, 2022
claim
Mar. 31, 2024
USD ($)
product
Mar. 31, 2023
USD ($)
Dec. 31, 2012
manufacturer
Mar. 04, 2024
Apr. 30, 2023
COMMITMENTS AND CONTINGENCIES                  
Lease term                 5 years
Number of products marketed without approved NDAs or ANDAs | product         4        
Total net revenues         $ 137,430 $ 106,786      
Payment for acquired intangible assets         0 4      
Number of plaintiffs | plaintiff   6              
Number of potential manufacturers | manufacturer             7    
Royalty percentage               5.00%  
Net sales percentage               5.00%  
Number of complaints filed | claim     200 2          
Alvogen Inc | Product Intellectual Property                  
COMMITMENTS AND CONTINGENCIES                  
Payment for acquired intangible assets $ 2,000                
Novitium                  
COMMITMENTS AND CONTINGENCIES                  
Number of complaints filed | claim     28            
Unapproved Products                  
COMMITMENTS AND CONTINGENCIES                  
Total net revenues         4,100 3,700      
Unapproved Products | Contract Customer                  
COMMITMENTS AND CONTINGENCIES                  
Total net revenues         $ 100 $ 600